A rare gene change triggered inflammation, and an interleukin-1 blocker helped
A change in the CDC42 gene was linked to a previously unrecognized inflammatory condition. Experiments showed that the change activates pyrin, while testing found that an interleukin-1 blocker was therapeutically effective for this condition.
·41 views